Phase 2 Bipolar I Disorder Clinical Trials
8 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–8 of 8 trials
Recruiting
Phase 1Phase 2
Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine
SchizophreniaMajor Depressive DisorderBipolar I Disorder
Mapi Pharma Ltd.24 enrolled6 locationsNCT07185815
Recruiting
Phase 1Phase 2
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder
Bipolar I Disorder
Alzamend Neuro, Inc.20 enrolled1 locationNCT07540338
Recruiting
Phase 2
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
Bipolar I Disorder
LB Pharmaceuticals Inc.320 enrolled3 locationsNCT07494305
Recruiting
Phase 2
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
Bipolar I DisorderBipolar II Disorder
AbbVie195 enrolled29 locationsNCT06696755
Recruiting
Phase 2
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
Bipolar I DisorderMania
Neurocrine Biosciences150 enrolled6 locationsNCT07288320
Recruiting
Phase 2
Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder
Depression, AnxietyStressBipolar I Disorder
Mclean Hospital40 enrolled1 locationNCT05837104
Recruiting
Phase 2
Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
Cannabis UseBipolar DisorderSchizoaffective Disorder, Bipolar Type+5 more
Medical University of South Carolina68 enrolled1 locationNCT05064319
Recruiting
Phase 2
NMDA Receptor Modulation for the Treatment of Bipolar I Disorder
Bipolar I Disorder
China Medical University Hospital90 enrolled1 locationNCT05977023